• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌与急性憩室炎患者不良临床结局的关联:一项全国性研究。

Association of Clostridioides difficile with adverse clinical outcomes in patients with acute diverticulitis: A nationwide study.

机构信息

Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Cooper Medical School of Rowan University, Camden, New Jersey, USA.

出版信息

J Gastroenterol Hepatol. 2021 Apr;36(4):983-989. doi: 10.1111/jgh.15240. Epub 2020 Sep 10.

DOI:10.1111/jgh.15240
PMID:32870544
Abstract

BACKGROUND AND AIM

Acute diverticulitis (AD) is a common gastrointestinal disease with a significant health care-associated burden. Patients hospitalized with AD have many risk factors for developing Clostridioides difficile infection (CDI). CDI is associated with poor outcomes in many diseases but has yet to be studied in AD.

METHODS

We utilized data from the National Inpatient Sample from January 2012 to October 2015 for patients hospitalized with AD and CDI compared with AD alone. Primary outcomes, which were mortality, length of stay, and hospitalization cost, were compared. Secondary outcomes were complications of diverticulitis and need for surgical interventions. Risk factors for mortality in AD and risk factors associated with CDI in AD patients were analyzed.

RESULTS

Among 767 850 hospitalizations for AD, 8755 also had CDI. A propensity score-matched cohort analysis demonstrated that CDI was associated with increased risk of inpatient mortality (odds ratio [OR] 2.78, 95% confidence interval [CI] 1.30, 5.95), prolonged duration of hospitalization by 4.27 days (P < 0.0001), total hospital cost by $33 271 (P < 0.0001), need for surgery (OR 1.45, 95% CI 1.22, 1.71), and complications of diverticulitis (OR 1.45, 95% CI 1.21, 1.74). Predictors of CDI among patients with AD included female gender (1.12 OR, 95% CI 1.01, 1.24), three or more comorbidities (1.81 OR, 95% CI 1.57, 2.09), and admissions to teaching hospitals (1.44 OR, 95% CI 1.22, 1.70).

CONCLUSIONS

Clostridioides difficile infection in AD is associated with increased mortality, length of stay, and hospital cost. Preventative measures should be made for at-risk patients with AD to decrease infection rate and poor outcomes.

摘要

背景与目的

急性憩室炎(AD)是一种常见的胃肠道疾病,具有显著的医疗保健相关负担。患有 AD 的住院患者有许多发生艰难梭菌感染(CDI)的风险因素。CDI 与许多疾病的不良结局相关,但尚未在 AD 中进行研究。

方法

我们利用了 2012 年 1 月至 2015 年 10 月全国住院患者样本的数据,比较了同时患有 AD 和 CDI 的患者与仅患有 AD 的患者。比较了主要结局(死亡率、住院时间和住院费用)。次要结局为憩室炎并发症和手术干预需求。分析了 AD 患者死亡的危险因素以及与 AD 患者 CDI 相关的危险因素。

结果

在 767850 例 AD 住院患者中,8755 例同时患有 CDI。倾向评分匹配队列分析表明,CDI 与住院死亡率增加相关(比值比 [OR] 2.78,95%置信区间 [CI] 1.30,5.95),住院时间延长 4.27 天(P<0.0001),总住院费用增加 33271 美元(P<0.0001),需要手术(OR 1.45,95%CI 1.22,1.71),以及憩室炎并发症(OR 1.45,95%CI 1.21,1.74)。AD 患者中 CDI 的预测因素包括女性(1.12 OR,95%CI 1.01,1.24)、三种或更多合并症(1.81 OR,95%CI 1.57,2.09)和入住教学医院(1.44 OR,95%CI 1.22,1.70)。

结论

AD 中的 CDI 与死亡率增加、住院时间延长和住院费用增加相关。应针对 AD 高危患者采取预防措施,以降低感染率和不良结局。

相似文献

1
Association of Clostridioides difficile with adverse clinical outcomes in patients with acute diverticulitis: A nationwide study.艰难梭菌与急性憩室炎患者不良临床结局的关联:一项全国性研究。
J Gastroenterol Hepatol. 2021 Apr;36(4):983-989. doi: 10.1111/jgh.15240. Epub 2020 Sep 10.
2
Outcomes of in Patients with Vitamin D Deficiency: A Propensity-Matched National Inpatient Sample Analysis.维生素 D 缺乏症患者的结局:一项基于倾向评分匹配的全国住院患者样本分析。
South Med J. 2020 Nov;113(11):593-599. doi: 10.14423/SMJ.0000000000001168.
3
Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.血管外科艰难梭菌感染的趋势、危险因素及成本
Ann Vasc Surg. 2015;29(4):792-800. doi: 10.1016/j.avsg.2014.10.031. Epub 2015 Jan 14.
4
Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.艰难梭菌感染与儿童死亡风险增加和住院时间延长相关。
Clin Infect Dis. 2013 Jul;57(1):1-8. doi: 10.1093/cid/cit155. Epub 2013 Mar 26.
5
Analysis of Clostridium difficile infections after cardiac surgery: epidemiologic and economic implications from national data.心脏手术后艰难梭菌感染分析:来自国家数据的流行病学和经济影响
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2404-9. doi: 10.1016/j.jtcvs.2014.04.017. Epub 2014 Apr 13.
6
Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH.非酒精性脂肪性肝病和非酒精性脂肪性肝炎患者艰难梭菌感染的结局和死亡风险因素。
Ann Hepatol. 2024 Jul-Aug;29(4):101510. doi: 10.1016/j.aohep.2024.101510. Epub 2024 May 5.
7
Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.2010年至2013年间艰难梭菌感染的负担:来自东欧一个学术中心的趋势和结果。
World J Gastroenterol. 2015 Jun 7;21(21):6728-35. doi: 10.3748/wjg.v21.i21.6728.
8
Cannabis use and risk of Clostridioides difficile infection: Analysis of 59,824 hospitalizations.大麻使用与艰难梭菌感染风险:59824 例住院患者分析。
Anaerobe. 2020 Feb;61:102095. doi: 10.1016/j.anaerobe.2019.102095. Epub 2019 Sep 4.
9
Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.2012 年至 2016 年期间美国住院患者中艰难梭菌(艰难梭菌)感染的负担。
J Hosp Infect. 2019 Jun;102(2):135-140. doi: 10.1016/j.jhin.2019.01.020. Epub 2019 Jan 25.
10
Acute kidney injury impact on inpatient mortality in Clostridium difficile infection: A national propensity-matched study.艰难梭菌感染患者的急性肾损伤对住院死亡率的影响:一项全国倾向匹配研究。
J Gastroenterol Hepatol. 2018 Jun;33(6):1227-1233. doi: 10.1111/jgh.14064. Epub 2018 Feb 26.

引用本文的文献

1
A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States.美国艰难梭菌感染的危险因素及发生时间的系统文献综述
Infect Dis Ther. 2024 Feb;13(2):273-298. doi: 10.1007/s40121-024-00919-0. Epub 2024 Feb 13.
2
Microbiota-Based Live Biotherapeutic RBX2660 for the Reduction of Recurrent Infection in Older Adults With Underlying Comorbidities.基于微生物群的活体生物疗法RBX2660用于降低患有基础合并症的老年人复发性感染的发生率。
Open Forum Infect Dis. 2022 Dec 30;10(1):ofac703. doi: 10.1093/ofid/ofac703. eCollection 2023 Jan.